D-cycloserine

D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.

Cross Reference

Introduction

To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with D-cycloserine?

D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with D-cycloserine

MeSH term MeSH ID Detail
Starvation D013217 47 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with D-cycloserine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with D-cycloserine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with D-cycloserine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with D-cycloserine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with D-cycloserine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with D-cycloserine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with D-cycloserine

Download all related citations
Per page 10 20 50 100 | Total 2271
Authors Title Published Journal PubMed Link
pmid:16296047
Baghaei P et al. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran. Am J Ther pmid:20019591
pmid:23342661
pmid:
Nadeau SE et al. A pilot randomized controlled trial of D-cycloserine and distributed practice as adjuvants to constraint-induced movement therapy after stroke. Neurorehabil Neural Repair pmid:24769437
Sharma B et al. Cycloserine-induced psychosis in a young female with drug-resistant tuberculosis. Gen Hosp Psychiatry pmid:24766906
CYCLOSERINE. 1955 Br Med J pmid:14363816
STEENKEN W and WOLINSKY E Cycloserine: antituberculous activity in vitro and in the experimental animal. 1956 Am Rev Tuberc pmid:13302684
NEILANDS JB Metal and hydrogen-ion binding properties of cycloserine. 1956 Arch. Biochem. Biophys. pmid:13314649
WOODSIDE JM et al. Spectrophotometric determination of cycloserine and isoniazid in pharmaceutical preparations. 1957 J Am Pharm Assoc Am Pharm Assoc pmid:13491492
HERROLD RD Some considerations in the administration of novobiocin and cycloserine. 1957 J. Urol. pmid:13439702
ANDREJEW A et al. [Effect of d-cycloserine & isonicotinic acid hydrazide on the catalase activity of Mycobacteria]. 1958 Biochim. Biophys. Acta pmid:13584402
HUGHES J et al. Cycloserine in chronic urinary infections. 1958 J. Urol. pmid:13564591
WEISERT O Some investigations relating to resistance determination of tubercle bacilli on cycloserine-containing Lowenstein-Jensen medium. 1958 Acta Pathol Microbiol Scand pmid:13532707
PORTARSKI G and VASILEV VKh [Treatment of chronic fibrocavernous pulmonary tuberculosis with cycloserine]. 1959 Suvr Med (Sofiia) pmid:14434255
RANDOWA D and PRUS-PASLAWSKA J [Use of cycloserine in the treatment of chronic pulmonary tuberculosis]. 1959 Gruzlica pmid:14436163
ROGNATO C [Cycloserine and its use in pulmonary tuberculosis]. 1959 Arcisp S Anna Ferrara pmid:14438397
ROGNATO C [Electrophoretic picture, serum agglutinins, sedimentation rate and allergometry during cycloserine treatment. 5]. 1959 Arcisp S Anna Ferrara pmid:14438398
SCARPA A and ZANELLA A [Endocavitary aspiration with the aid of local introduction of prednisolone derivatives and chemoantibiotics]. 1959 Riforma Med pmid:14442245
HEIN J and BERTHOLD H [On cycloserine-therapy]. 1959 Schweiz Z Tuberc Pneumonol pmid:14400685
HOLMES CX et al. The role of the cycloserine (seromycin) blood level in the treatment of pulmonary tuberculosis and the prevention and control of cycloserine (seromycin) toxicity. 1959 Dis Chest pmid:14402775
AGRESTI E [Results and clinical aspects of the use of cycloserine in mental patients with tuberculosis]. 1959 Riv Patol Nerv Ment pmid:13792070
ANDREJEW A et al. [Action of D-cycloserine on catalase and peroxidase]. 1959 C. R. Seances Soc. Biol. Fil. pmid:13793558
BLASI A et al. [Observations on the action of cycloserine in experimental ocular tuberculosis in the rabbit]. 1959 Lotta Tuberc pmid:13801353
BLASI A et al. [The action of cycloserine in experimental tuberculosis (Comparative studies between the histologic aspects and the level of concentration in the tissues)]. 1959 Arch Tisiol Mal Appar Respir pmid:13801355
BONOLA A and BEDESCHI P [Clinical observations on the use of cycloserine in osteoarticular tuberculosis]. 1959 Minerva Ortop pmid:13802593
DUMON G [New antibiotics and pulmonary tuberculosis (viomycin, cycloserine, neomycin)]. 1959 Mars Med pmid:13818595
WIEDMAN M and TURTZ AI Antibiotics in herpes simplex and an experimental and clinical investigation of cycloserine. 1959 Am. J. Ophthalmol. pmid:13844589
WOLINSKY E and KAPUR VN Evaluation of cycloserine with high dosage of isoniazid in chronic treatment-failure pulmonary tuberculosis. 1959 Am. Rev. Respir. Dis. pmid:13845748
BUGIARDINI G et al. [Urinary elimination of 17-ketosteroids in subjects treated with cycloserine]. 1959 Arcisp S Anna Ferrara pmid:13849226
ROGNATO C et al. [Hematic levels of cycloserine in relation to seasonal temperature]. 1959 Arcisp S Anna Ferrara pmid:13854547
ROGNATO C and ZAMPINI N [Urinary elimination of cycloserine in man]. 1959 Arcisp S Anna Ferrara pmid:13854548
GIRAUD P et al. [New evaluation of the treatment of severe infantile tuberculosis by cycloserine and viomycin]. 1959 Pediatrie pmid:13828143
STILLER AF and BARROWS W Treatment of pulmonary tuberculosis with seromycin. 1959 J Mich State Med Soc pmid:13834681
STORNIELLO G and OLIA A [Analogies in the morphological behavior of some tuberculous lesions in respect to treatment with PAS and cycloserine]. 1959 Lotta Tuberc pmid:13834983
TITZE B [Clinical-roentgenological results in therapy of pulmonary tuberculosis with D-cycloserine]. 1959 Beitr Klin Tuberk Spezif Tuberkuloseforsch pmid:13838533
TSUKAMURA M et al. A genetic study on the cycloserine-resistance of Mycobacterium tuberculosis var. hominis. 1959 Jpn. J. Microbiol. pmid:13839676
LEITES V Cycloserine-isoniazid in the ambulatory treatment of active tuberculosis after failure of previous chemotherapy. 1959 Am. Rev. Respir. Dis. pmid:13670395
SCARDI V and BONAVITA V Simultaneous determination of isoniazid and d-cycloserine by sodium pentacyanoammineferroate. 1959 Clin. Chim. Acta pmid:13639256
LEBASCLE J and CHENEBAULT J [Electroencephalographic study of 50 pulmonary tuberculotics treated by cycloserine]. 1959 Rev Tuberc Pneumol (Paris) pmid:14414981
LOW B et al. [Cycloserine: a new antibiotic for the treatment of tuberculosis]. 1959 Tuberkulozis pmid:14418512
MORIARTY MA Cycloserine in pulmonary tuberculosis. 1959 J Ir Med Assoc pmid:14424161
MURDOCH JM et al. Cycloserine in treatment of infection of urinary tract. 1959 Br Med J pmid:14425338
OSEGLIA G and SALVETTI F [Prevention of neuropsychiatric disorders in pulmonary tuberculotics treated with cycloserine]. 1959 Minerva Med. pmid:14429207
PARRAVICINI C and RAMPINI GF [Cycloserine in the treatment of chronic pulmonary tuberculosis; first clinical results]. 1959 Riv Patol Clin pmid:14430582
PICHA E [Treatment of infections of the excretory urinary tract with D-cycloserine]. 1959 Wien Med Wochenschr pmid:14432724
SHOCKMAN GD Reversal of cycloserine inhibition by D-alanine. 1959 Aug-Sep Proc. Soc. Exp. Biol. Med. pmid:14446135
CAMURATI E et al. [Results of cycloserine therapy in patients with pulmonary tuberculosis (Casuistic contribution)]. 1959 Jul-Aug G Ital Tuberc Mal Torace pmid:13807348
LANGUILLON J and CLARY J [Treatment of Hansen's disease using d-cycloserine]. 1959 Jul-Aug Med Trop (Mars) pmid:14414036
GHISLANDI E [Chemotherapy of silicotuberculosis: experience with pyrazinamide and cycloserine]. 1959 Jun-Jul Med Lav pmid:13827761